A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways
2007
Hematology ASH Education Program
Mantle cell lymphoma (MCL) remains one of the more challenging sub-types of non-Hodgkin lymphoma. This entity, which is only approximately 10 years old, is characterized by response to many different chemotherapy regimens, though the duration of those responses remains often times quite short. Retreatment with second and third line combination regimens results in shorter and shorter durations of response, with the rapid emergence of a very drugresistant phenotype. Despite these often
doi:10.1182/asheducation-2007.1.270
pmid:18024640
fatcat:cflrsue6bnfl3lbytemwbxqjwi